Menoufia University
Shibīn al Kawm, Menoufia, 32511, Egypt
NCT Number: NCT06243822
this study is to assess the hemodynamic profile of ketamine compared with propofol in critically ill, mechanically ventilated adult Patients study will be carried out on 100 mechanically ventilated patients who received one sedative agent propofol or ketamine The patients will be randomized into two equal groups to receive either ketamine or propofol Group 1 (Ketamine group): ketamine is initiated at 0.5 mg/kg/h and titrated by 0.25 mg/kg/h every 15 minutes to a maximum dosage of 4 mg/kg/h to achieve appropriate sedation. Group 2 (Propofol group): Propofol is initiated at 0.3 to 0.6 mg /kg/hr. and titrated by 0.3 to 0.6 mg/kg/h every 5 to 10 minutes up to a maximum dosage of 4.5 to 4.8 mg/kg/hr. to achieve appropriate sedation.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Shibīn al Kawm, Menoufia, 32511, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ketamine is initiated at 0.5 mg/kg/h and titrated by 0.25 mg/kg/h every 15 minutes to a maximum dosage of 4 mg/kg/h to achieve appropriate sedation.
Propofol is initiated at 0.3 to 0.6 mg /kg/hr. and titrated by 0.3 to 0.6 mg/kg/h every 5 to 10 minutes up to a maximum dosage of 4.5 to 4.8 mg/kg/hr. to achieve appropriate sedation.
Time frame: every 15 min for the first hour then every hour for next six hours then every six hours for 48 hours
measure heart rate
Time frame: every 15 min for the first hour then every hour for next six hours then every six hours for 48 hours
measure mean arterial blodd pressure
Menoufia University
Other
Hemodynamic Effects of Ketamine Compared With Propofol as Continuous ICU Sedation in Mechanically Ventilated Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06412861
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Samsun, Turkey (Türkiye)
View Trial DetailsNCT07222007
Airway Management, Critical Illness
Jacksonville, Florida, United States
View Trial DetailsNCT05615948
Agnosia, Analgesia
Brooklyn, New York, United States
View Trial DetailsNCT07135154
Body Weight, General Anesthetic
Balıkesir, Turkey (Türkiye)
View Trial Details